Positron emission tomography harmonization in the Alzheimer's Disease Neuroimaging Initiative: A scalable and rigorous approach to multisite amyloid and tau quantification

被引:2
|
作者
Landau, Susan M. [1 ]
Harrison, Theresa M. [1 ]
Baker, Suzanne L. [2 ]
Boswell, Martin S. [2 ]
Lee, JiaQie [1 ]
Taggett, Jacinda [1 ]
Ward, Tyler J. [1 ]
Chadwick, Trevor [1 ]
Murphy, Alice [1 ]
DeCarli, Charles [3 ]
Schwarz, Christopher G. [4 ]
Vemuri, Prashanthi [4 ]
Jack Jr, Clifford R. [4 ]
Koeppe, Robert A. [5 ]
Jagust, William J. [1 ,2 ]
机构
[1] Univ Calif Berkeley, Neurosci Dept, Berkeley, CA USA
[2] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging, Berkeley, CA 94720 USA
[3] Univ Calif Davis, Davis, CA USA
[4] Mayo Clin, Dept Radiol, Rochester, MN USA
[5] Univ Michigan, Dept Radiol, Ann Arbor, MI USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; A beta PET; tau PET; WHITE-MATTER REFERENCE; PITTSBURGH COMPOUND-B; PET;
D O I
10.1002/alz.14378
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
INTRODUCTION: A key goal of the Alzheimer's Disease NeuroImaging Initiative (ADNI) positron emission tomography (PET) Core is to harmonize quantification of beta-amyloid (A beta) and tau PET image data across multiple scanners and tracers. METHODS: We developed an analysis pipeline (Berkeley PET Imaging Pipeline, B-PIP) for ADNI A beta and tau PET images and applied it to PET data from other multisite studies. Steps include image pre-processing, refacing, magnetic resonance imaging (MRI)/PET co-registration, visual quality control (QC), quantification of tracer uptake, and standardization of A beta and tau standardized uptake value ratios (SUVrs) across tracers. RESULTS: Measurements from 10,105 cross-sectional and longitudinal A beta and tau PET scans acquired in several studies between 2010 and 2024 can be processed, harmonized, and directly merged across tracers and cohorts. DISCUSSION: The B-PIP developed in ADNI is a scalable image harmonization approach used in several observational studies and clinical trials that facilitates rigorous A beta and tau PET quantification and data sharing.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Radiopharmaceuticals for positron emission tomography investigations of Alzheimer's disease
    Nagren, Kjell
    Halldin, Christer
    Rinne, Juha O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (08) : 1575 - 1593
  • [42] Positron-emission tomography and Alzheimer's disease - Reply
    Reiman, EM
    Caselli, RJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (03): : 207 - 208
  • [43] The role of positron emission tomography in the diagnosis of Alzheimer's disease
    Cummings, JL
    Silverman, D
    Small, G
    Phelps, M
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (03) : 467 - 468
  • [44] Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease
    Leuzy, Antoine
    Smith, Ruben
    Cullen, Nicholas C.
    Strandberg, Olof
    Vogel, Jacob W.
    Binette, Alexa Pichet
    Borroni, Edilio
    Janelidze, Shorena
    Ohlsson, Tomas
    Jogi, Jonas
    Ossenkoppele, Rik
    Palmqvist, Sebastian
    Mattsson-Carlgren, Niklas
    Klein, Gregory
    Stomrud, Erik
    Hansson, Oskar
    JAMA NEUROLOGY, 2022, 79 (02) : 149 - 158
  • [45] Neuroimaging statistical approaches for determining neural correlates of Alzheimer's disease via positron emission tomography imaging
    Drake, Daniel
    Derado, Gordana
    Zhang, Lijun
    Bowman, F. DuBois
    WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL STATISTICS, 2023, 15 (05):
  • [46] Beta amyloid, tau, neuroimaging, and cognition: sequence modeling of biomarkers for Alzheimer’s Disease
    S. Duke Han
    Jonathan Gruhl
    Laurel Beckett
    Hiroko H. Dodge
    Nikki H. Stricker
    Sarah Farias
    Dan Mungas
    Brain Imaging and Behavior, 2012, 6 : 610 - 620
  • [47] Beta amyloid, tau, neuroimaging, and cognition: sequence modeling of biomarkers for Alzheimer's Disease
    Han, S. Duke
    Gruhl, Jonathan
    Beckett, Laurel
    Dodge, Hiroko H.
    Stricker, Nikki H.
    Farias, Sarah
    Mungas, Dan
    BRAIN IMAGING AND BEHAVIOR, 2012, 6 (04) : 610 - 620
  • [48] Beta Amyloid, Tau, Neuroimaging, and Cognition: Sequence Modeling of Biomarkers for Alzheimer's Disease
    Han, S. Duke
    Gruhl, Jonathan
    Beckett, Laurel
    Dodge, Hiroko
    Stricker, Nikki
    Farias, Sarah
    Mungas, Dan
    NEUROLOGY, 2012, 78
  • [49] Functional Abnormality Associated With Tau Deposition in Alzheimer's Disease - A Hybrid Positron Emission Tomography/MRI Study
    Fu, Liping
    Zhou, Zhi
    Liu, Linwen
    Zhang, Jinming
    Xie, Hengge
    Zhang, Xiaojun
    Zhu, Mingwei
    Wang, Ruimin
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13